Literature DB >> 31818819

Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.

Fiona Hui-Sian Wong1, Yiying Cai1,2, Hui Leck1, Tze-Peng Lim1, Jocelyn Qi-Min Teo1,3, Winnie Lee1, Tse Hsien Koh4, Thuan Tong Tan5, Kar Wai Tan6, Andrea Lay-Hoon Kwa7,2,8.   

Abstract

Polymyxin B-based combinations are increasingly prescribed as a last-line option against extensively drug-resistant (XDR) Acinetobacter baumannii It is unknown if such combinations can result in the development of nondividing persister cells in XDR A. baumannii We investigated persister development upon exposure of XDR A. baumannii to polymyxin B-based antibiotic combinations using flow cytometry. Time-kill studies (TKSs) were conducted in three nonclonal XDR A. baumannii strains with 5 log10 CFU/ml bacteria against polymyxin B alone and polymyxin B-based two-drug combinations over 24 h. At different time points, samples were obtained and enumerated by viable plating and flow cytometry. Propidium iodide and carboxyfluorescein succinimidyl ester dyes were used to differentiate between live and dead cells and between dividing and nondividing cells, respectively, at the single-cell level, and nondividing live cells were resuscitated and characterized phenotypically. Our results from viable plating showed that polymyxin B plus meropenem and polymyxin B plus rifampin were each bactericidal (>99.9% kill compared to the initial inoculum) against 2/3 XDR A. baumannii strains at 24 h. By flow cytometry, however, none of the combinations were bactericidal against XDR A. baumannii at 24 h. Further analysis using cellular dyes in flow cytometry revealed that upon exposure to polymyxin B-based combinations, XDR A. baumannii entered a viable but nondividing persister state. These bacterial cells reinitiated division upon the removal of antibiotic pressure and did not have a growth deficit compared to the parent strain. We conclude that persister cells develop in XDR A. baumannii upon exposure to polymyxin B-based combinations and that nonplating methods appear to complement viable-plating methods in describing the killing activity of polymyxin B-based combinations against XDR A. baumannii.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  antibiotic persistence; carbapenem-resistant A. baumannii; time-kill study; tolerance

Mesh:

Substances:

Year:  2020        PMID: 31818819      PMCID: PMC7038294          DOI: 10.1128/AAC.01712-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

3.  Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.

Authors:  Ana M Sandri; Cornelia B Landersdorfer; Jovan Jacob; Márcio M Boniatti; Micheline G Dalarosa; Diego R Falci; Tainá F Behle; Rosaura C Bordinhão; Jiping Wang; Alan Forrest; Roger L Nation; Jian Li; Alexandre P Zavascki
Journal:  Clin Infect Dis       Date:  2013-05-22       Impact factor: 9.079

Review 4.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 5.  Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.

Authors:  Bram Van den Bergh; Maarten Fauvart; Jan Michiels
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

6.  Variation in formation of persister cells against colistin in Acinetobacter baumannii isolates and its relationship with treatment failure.

Authors:  Eun Seon Chung; Yu Mi Wi; Kwan Soo Ko
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

7.  Antibiotic tolerance facilitates the evolution of resistance.

Authors:  Irit Levin-Reisman; Irine Ronin; Orit Gefen; Ilan Braniss; Noam Shoresh; Nathalie Q Balaban
Journal:  Science       Date:  2017-02-09       Impact factor: 47.728

8.  Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence.

Authors:  Bram Van den Bergh; Joran E Michiels; Tom Wenseleers; Etthel M Windels; Pieterjan Vanden Boer; Donaat Kestemont; Luc De Meester; Kevin J Verstrepen; Natalie Verstraeten; Maarten Fauvart; Jan Michiels
Journal:  Nat Microbiol       Date:  2016-03-07       Impact factor: 17.745

9.  Modelling time-kill studies to discern the pharmacodynamics of meropenem.

Authors:  Vincent H Tam; Amy N Schilling; Michael Nikolaou
Journal:  J Antimicrob Chemother       Date:  2005-03-16       Impact factor: 5.790

10.  Estimation of cell proliferation dynamics using CFSE data.

Authors:  H T Banks; Karyn L Sutton; W Clayton Thompson; Gennady Bocharov; Dirk Roose; Tim Schenkel; Andreas Meyerhans
Journal:  Bull Math Biol       Date:  2010-03-03       Impact factor: 1.758

View more
  5 in total

1.  Tobramycin Stress Induced Differential Gene Expression in Acinetobacter baumannii.

Authors:  Shruti Kashyap; Prince Sharma; Neena Capalash
Journal:  Curr Microbiol       Date:  2022-02-07       Impact factor: 2.188

2.  A Robust Method for Generating, Quantifying, and Testing Large Numbers of Escherichia coli Persisters.

Authors:  Silke R Vedelaar; Jakub L Radzikowski; Matthias Heinemann
Journal:  Methods Mol Biol       Date:  2021

3.  Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia.

Authors:  Guangxue Hu; Wanzong Liu; Mali Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-31       Impact factor: 2.650

4.  Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation.

Authors:  Hasini Wickremasinghe; Heidi H Yu; Mohammad A K Azad; Jinxin Zhao; Phillip J Bergen; Tony Velkov; Qi Tony Zhou; Yan Zhu; Jian Li
Journal:  Antibiotics (Basel)       Date:  2021-04-08

Review 5.  Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment.

Authors:  Soroosh Monem; Beata Furmanek-Blaszk; Adrianna Łupkowska; Dorota Kuczyńska-Wiśnik; Karolina Stojowska-Swędrzyńska; Ewa Laskowska
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.